NCT03433560 2024-05-14
An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)
Kyowa Kirin Co., Ltd.
Completed
Clinical Trials
12 trialsNCT05793073 2023-03-31
AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients
Centre Hospitalier Universitaire de Nice
Completed
NCT04914702 2022-07-11
Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Insel Gruppe AG, University Hospital Bern
Completed
NCT02702583 2021-11-29
ORA-FEBRIS
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Completed
NCT04134429 2021-07-08
Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy
Insel Gruppe AG, University Hospital Bern
Completed
NCT04910698 2021-06-02
Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia
Poitiers University Hospital
Completed
NCT04460079 2020-07-07
Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN
Cinnagen
Completed
NCT02856204 2019-05-16
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
Stanford University
Completed
NCT00503854 2018-10-22
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
M.D. Anderson Cancer Center
Completed
NCT02906254 2016-09-20
ANTIBIOSTOP
University Hospital, Brest
Completed
NCT01459653 2016-01-11
Monitor-GCSF
Sandoz
Completed
NCT01706562 2013-02-20
A Study of Empirical Antifungal Therapy With Itraconazole
Janssen Korea, Ltd., Korea
Completed